Skip to main content
Nanobiotix S.A. (EPA:NANO)
France flag France · Delayed Price · Currency is EUR
28.38
+0.04 (0.14%)
Apr 29, 2026, 12:39 PM CET

Nanobiotix Revenue

In the year 2025, Nanobiotix had annual revenue of 32.59M EUR, down -553.25%. Nanobiotix had revenue of 5.96M in the half year ending December 31, 2025, a decrease of -81.91%.

Revenue
32.59M
Revenue Growth
-553.25%
P/S Ratio
42.17
Revenue / Employee
316.44K
Employees
103
Market Cap
1.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202532.59M39.78M-553.25%
Dec 31, 2024-7.19M-43.40M-119.86%
Dec 31, 202336.21M31.43M658.10%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M322.00K13.85%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DBV Technologies 4.80M
Inventiva 6.76M
MedinCell 32.44M
Valneva SE 174.66M
Genfit 65.43M
ABIVAX Société Anonyme 4.57M
Cellectis 67.79M
Transgene 7.21M
Revenue Rankings

Nanobiotix News

More News